Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy

Shingo Miyamoto; Hiroshi Yagi; Fusanori Yotsumoto; Tatsuhiko Kawarabayashi; Eisuke Mekada

doi:10.1007/978-0-387-68969-2_23

Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy

Shingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, Tatsuhiko Kawarabayashi, Eisuke Mekada

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English
Title of host publication	Ovarian Cancer
Subtitle of host publication	State of the Art and Future Directions in Translational Research
Publisher	Springer New York
Pages	281-295
Number of pages	15
ISBN (Print)	9780387689661
DOIs	https://doi.org/10.1007/978-0-387-68969-2_23
Publication status	Published - Jan 1 2008
Externally published	Yes

Publication series

Name	Advances in Experimental Medicine and Biology
Volume	622
ISSN (Print)	0065-2598

All Science Journal Classification (ASJC) codes

Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-0-387-68969-2_23

Cite this

Miyamoto, S., Yagi, H., Yotsumoto, F., Kawarabayashi, T., & Mekada, E. (2008). Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. In Ovarian Cancer: State of the Art and Future Directions in Translational Research (pp. 281-295). (Advances in Experimental Medicine and Biology; Vol. 622). Springer New York. https://doi.org/10.1007/978-0-387-68969-2_23

Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. / Miyamoto, Shingo; Yagi, Hiroshi; Yotsumoto, Fusanori et al.
Ovarian Cancer: State of the Art and Future Directions in Translational Research. Springer New York, 2008. p. 281-295 (Advances in Experimental Medicine and Biology; Vol. 622).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Miyamoto, S, Yagi, H, Yotsumoto, F, Kawarabayashi, T & Mekada, E 2008, Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. in Ovarian Cancer: State of the Art and Future Directions in Translational Research. Advances in Experimental Medicine and Biology, vol. 622, Springer New York, pp. 281-295. https://doi.org/10.1007/978-0-387-68969-2_23

@inbook{b039d934b11b4212b642e23294f6e632,

title = "Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy",

author = "Shingo Miyamoto and Hiroshi Yagi and Fusanori Yotsumoto and Tatsuhiko Kawarabayashi and Eisuke Mekada",

year = "2008",

month = jan,

day = "1",

doi = "10.1007/978-0-387-68969-2_23",

language = "English",

isbn = "9780387689661",

series = "Advances in Experimental Medicine and Biology",

publisher = "Springer New York",

pages = "281--295",

booktitle = "Ovarian Cancer",

address = "United States",

}

TY - CHAP

T1 - Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy

AU - Miyamoto, Shingo

AU - Yagi, Hiroshi

AU - Yotsumoto, Fusanori

AU - Kawarabayashi, Tatsuhiko

AU - Mekada, Eisuke

PY - 2008/1/1

Y1 - 2008/1/1

UR - http://www.scopus.com/inward/record.url?scp=84934443762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934443762&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68969-2_23

DO - 10.1007/978-0-387-68969-2_23

M3 - Chapter

C2 - 18546636

AN - SCOPUS:84934443762

SN - 9780387689661

T3 - Advances in Experimental Medicine and Biology

SP - 281

EP - 295

BT - Ovarian Cancer

PB - Springer New York

ER -

Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy

Publication series

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this